The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: A systematic review and meta-analysis

Published:2016-10 Issue: Volume:221 Page:746-754
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Ambrosino Pasquale,Lupoli Roberta,Di Minno Alessandro,Tarantino Luciano,Spadarella Gaia,Tarantino Paolo,Nasto Aurelio,Celentano Aldo,Di Minno Matteo Nicola Dario^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference68 articles.

1. Epidemiology of hepatitis C: geographic differences and temporal trends;Wasley;Semin. Liver Dis.,2000

2. Hepatitis C virus infection;Lauer;N. Engl. J. Med.,2001

3. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection;Conry-Cantilena;N. Engl. J. Med.,1996

4. Natural history of chronic hepatitis C;Seeff;Hepatology (Baltimore),2002

5. Extrahepatic manifestations of hepatitis C virus infection;Zignego;Clin. Liver Dis.,2008

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters;Viruses;2024-02-27

2. Association between chronic viral infection‐related hospitalization and risk of cardiovascular disease: A population‐based cohort study;Journal of Medical Virology;2024-01

3. Viral infections in cardiometabolic risk and disease between old acquaintances and new enemies;Exploration of Cardiology;2023-12-27

4. The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease;European Journal of Gastroenterology & Hepatology;2023-09-27

5. Evaluation of left ventricular function after sofosbuvir and daclatasvir regimen for chronic hepatitis C;Journal of the Pakistan Medical Association;2023-05-25